134 related articles for article (PubMed ID: 25138722)
1. Characterizing Pluripotent Stem Cells Using the TaqMan® hPSC Scorecard(TM) Panel.
Fergus J; Quintanilla R; Lakshmipathy U
Methods Mol Biol; 2016; 1307():25-37. PubMed ID: 25138722
[TBL] [Abstract][Full Text] [Related]
2. A qPCR ScoreCard quantifies the differentiation potential of human pluripotent stem cells.
Tsankov AM; Akopian V; Pop R; Chetty S; Gifford CA; Daheron L; Tsankova NM; Meissner A
Nat Biotechnol; 2015 Nov; 33(11):1182-92. PubMed ID: 26501952
[TBL] [Abstract][Full Text] [Related]
3. Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors.
Shafa M; Sjonnesen K; Yamashita A; Liu S; Michalak M; Kallos MS; Rancourt DE
J Tissue Eng Regen Med; 2012 Jun; 6(6):462-72. PubMed ID: 21761573
[TBL] [Abstract][Full Text] [Related]
4. Teratoma formation of human embryonic stem cells in three-dimensional perfusion culture bioreactors.
Stachelscheid H; Wulf-Goldenberg A; Eckert K; Jensen J; Edsbagge J; Björquist P; Rivero M; Strehl R; Jozefczuk J; Prigione A; Adjaye J; Urbaniak T; Bussmann P; Zeilinger K; Gerlach JC
J Tissue Eng Regen Med; 2013 Sep; 7(9):729-41. PubMed ID: 22438087
[TBL] [Abstract][Full Text] [Related]
5. A defined xeno-free and feeder-free culture system for the derivation, expansion and direct differentiation of transgene-free patient-specific induced pluripotent stem cells.
Lu HF; Chai C; Lim TC; Leong MF; Lim JK; Gao S; Lim KL; Wan AC
Biomaterials; 2014 Mar; 35(9):2816-26. PubMed ID: 24411336
[TBL] [Abstract][Full Text] [Related]
6. Generation of mice derived from induced pluripotent stem cells.
Boland MJ; Hazen JL; Nazor KL; Rodriguez AR; Martin G; Kupriyanov S; Baldwin KK
J Vis Exp; 2012 Nov; (69):e4003. PubMed ID: 23222420
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of primordial germ cells from induced pluripotent stem cells of primary ovarian insufficiency.
Leng L; Tan Y; Gong F; Hu L; Ouyang Q; Zhao Y; Lu G; Lin G
Hum Reprod; 2015 Mar; 30(3):737-48. PubMed ID: 25586786
[TBL] [Abstract][Full Text] [Related]
8. TaqMan® OpenArray® high-throughput transcriptional analysis of human embryonic and induced pluripotent stem cells.
Patel SN; Wu Y; Bao Y; Mancebo R; Au-Young J; Grigorenko E
Methods Mol Biol; 2013; 997():191-201. PubMed ID: 23546757
[TBL] [Abstract][Full Text] [Related]
9. Superior Red Blood Cell Generation from Human Pluripotent Stem Cells Through a Novel Microcarrier-Based Embryoid Body Platform.
Sivalingam J; Lam AT; Chen HY; Yang BX; Chen AK; Reuveny S; Loh YH; Oh SK
Tissue Eng Part C Methods; 2016 Aug; 22(8):765-80. PubMed ID: 27392822
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of human placenta as a source of the universal feeder in human and mouse pluripotent stem cell culture.
Park Y; Lee SJ; Choi IY; Lee SR; Sung HJ; Kim JH; Yoo YD; Geum DH; Kim SH; Kim BS
Cell Reprogram; 2010 Jun; 12(3):315-28. PubMed ID: 20698773
[TBL] [Abstract][Full Text] [Related]
11. Techniques in embryoid body formation from human pluripotent stem cells.
Shevde NK; Mael AA
Methods Mol Biol; 2013; 946():535-46. PubMed ID: 23179854
[TBL] [Abstract][Full Text] [Related]
12. A Protocol for Culture and Characterization of Human Induced Pluripotent Stem Cells After Induction.
Cheng YS; Xu M; Chen G; Beers J; Chen CZ; Liu C; Zou J; Zheng W
Curr Protoc; 2023 Aug; 3(8):e866. PubMed ID: 37610273
[TBL] [Abstract][Full Text] [Related]
13. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
[TBL] [Abstract][Full Text] [Related]
14. Feeder-free derivation of induced pluripotent stem cells from human immature dental pulp stem cells.
Beltrão-Braga PC; Pignatari GC; Maiorka PC; Oliveira NA; Lizier NF; Wenceslau CV; Miglino MA; Muotri AR; Kerkis I
Cell Transplant; 2011; 20(11-12):1707-19. PubMed ID: 21457612
[TBL] [Abstract][Full Text] [Related]
15. Efficient induction of pluripotent stem cells from menstrual blood.
Li Y; Li X; Zhao H; Feng R; Zhang X; Tai D; An G; Wen J; Tan J
Stem Cells Dev; 2013 Apr; 22(7):1147-58. PubMed ID: 23151296
[TBL] [Abstract][Full Text] [Related]
16. The generation of embryoid bodies from feeder-based or feeder-free human pluripotent stem cell cultures.
Stover AE; Schwartz PH
Methods Mol Biol; 2011; 767():391-8. PubMed ID: 21822890
[TBL] [Abstract][Full Text] [Related]
17. Functional assays for human embryonic stem cell pluripotency.
O'Connor MD; Kardel MD; Eaves CJ
Methods Mol Biol; 2011; 690():67-80. PubMed ID: 21042985
[TBL] [Abstract][Full Text] [Related]
18. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage.
Li F; Bronson S; Niyibizi C
J Cell Biochem; 2010 Mar; 109(4):643-52. PubMed ID: 20039314
[TBL] [Abstract][Full Text] [Related]
19. A functionally characterized test set of human induced pluripotent stem cells.
Boulting GL; Kiskinis E; Croft GF; Amoroso MW; Oakley DH; Wainger BJ; Williams DJ; Kahler DJ; Yamaki M; Davidow L; Rodolfa CT; Dimos JT; Mikkilineni S; MacDermott AB; Woolf CJ; Henderson CE; Wichterle H; Eggan K
Nat Biotechnol; 2011 Mar; 29(3):279-86. PubMed ID: 21293464
[TBL] [Abstract][Full Text] [Related]
20. Growth of Human Pluripotent Stem Cells Using Functional Human Extracellular Matrix.
Sanz-Garcia A; Stojkovic M; Escobedo-Lucea C
Methods Mol Biol; 2016; 1307():39-60. PubMed ID: 25476443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
